热灌注联合腔内化疗治疗恶性胸腹水的临床分析  

Clinical Analysis of Treating Malignant Pleural Effusion with Hyperthermic Perfusion Combined with Intracavitary Chemotherapy

作　　者：魏漫 

机构地区：[1]重庆璧山区人民医院,重庆402760

出　　处：《数理医药学杂志》2016年第5期752-754,共3页Journal of Mathematical Medicine

摘　　要：目的：探究热灌注联合腔内化疗治疗恶性胸腹水的临床治疗效果.方法：选取自2013年2月-2015年2月某院收治的32例恶性胸腹水患者,随机分为实验组16例和对照组16例,实验组采用热灌注联合腔内化疗方法,对照组采用腔内化疗治疗方法,观察两组的临床治疗效果.结果：实验组的总有效率为93.8%明显高于对照组62.5%,经对比,两组患者差异具有统计学意义（P〈0.05）.结论：采用热灌注联合腔内化疗方法治疗恶性胸腹水患者,不仅方法简单,而且具有显著的临床治疗效果,能够有效地提升患者的生存质量.Objective:To explore the clinical effect of treating malignant pleural effusion with hyperthermic perfusion combined with intracavitary chemotherapy.Methods:32cases of patients with malignant pleural effusion in a hospital from February 2013 to February 2015 were randomly divided into experimental group and control group,16 cases in each group.The experimental group received hyperthermic perfusion combined with intracavitary chemotherapy,control group was treated with intracavitary chemotherapy,compare clinical treatment effect in both groups.Results:The total effective rate of the experimental group was 93.8%,significantly higher than 62.5% of the control group,difference between the two groups was statistically significant(P<0.05).Conclusion:Hyperthermic perfusion combined with intracavitary chemotherapy is not only simple,but also has significant clinical effect,which can effectively improve the quality of life of patients.

关 键 词：热灌注联合腔内化疗 恶性胸腹水 临床分析 

分 类 号：R730.5[医药卫生—肿瘤]